Found: 13
Select item for more details and to access through your institution.
Inactivation of LLC1 gene in nonsmall cell lung cancer.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 11, p. 2353, doi. 10.1002/ijc.22577
- By:
- Publication type:
- Article
Pharmacological stimulation of NQO1 decreases NADPH levels and ameliorates acute pancreatitis in mice.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41419-018-1252-z
- By:
- Publication type:
- Article
A national survey of lung cancer specialists’ views on low-dose CT screening for lung cancer in Korea.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0192626
- By:
- Publication type:
- Article
Catamenial Hemoptysis: A Nationwide Analysis in Korea.
- Published in:
- Respiration, 2010, v. 79, n. 4, p. 296, doi. 10.1159/000228831
- By:
- Publication type:
- Article
Effects of Banxia Xiexin Decoction (半夏泻心汤) on Cisplatin-Induced Apoptosis of Human A549 Lung Cancer Cells.
- Published in:
- Chinese Journal of Integrative Medicine, 2018, v. 24, n. 6, p. 436, doi. 10.1007/s11655-017-2922-x
- By:
- Publication type:
- Article
Healthcare utilization of lung cancer patients associated with exposure to fine particulate matter: A Korean cohort study.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 27, p. 2777, doi. 10.1111/1759-7714.15070
- By:
- Publication type:
- Article
Pharmacological activation of NQO1 increases NAD⁺ levels and attenuates cisplatin-mediated acute kidney injury in mice.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Pharmacological activation of NQO1 increases NAD<sup>+</sup> levels and attenuates cisplatin-mediated acute kidney injury in mice.
- Published in:
- Kidney International, 2014, v. 85, n. 3, p. 547, doi. 10.1038/ki.2013.330
- By:
- Publication type:
- Article
Restricting extracellular Ca<sup>2+</sup> on gefitinib-resistant non-small cell lung cancer cells reverses altered epidermal growth factor-mediated Ca<sup>2+</sup> response, which consequently enhances gefitinib sensitivity.
- Published in:
- PLoS ONE, 2020, v. 15, n. 8, p. 1, doi. 10.1371/journal.pone.0238155
- By:
- Publication type:
- Article
Pulmonary actinomycosis during the first decade of 21st century: cases of 94 patients.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non‐small‐cell lung cancer harboring EGFR mutations: Results from a real‐world study in South Korea.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 17, p. 5809, doi. 10.1002/cam4.4127
- By:
- Publication type:
- Article
Lung cancer specialist physicians’ attitudes towards e-cigarettes: A nationwide survey.
- Published in:
- PLoS ONE, 2017, v. 12, n. 2, p. 1, doi. 10.1371/journal.pone.0172568
- By:
- Publication type:
- Article
New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity.
- Published in:
- BioMed Research International, 2016, v. 2016, p. 1, doi. 10.1155/2016/4048390
- By:
- Publication type:
- Article